Literature DB >> 28660816

The role of antimicrobial sutures in preventing surgical site infection.

D Leaper1, P Wilson2, O Assadian3, C Edmiston4, M Kiernan5, A Miller6, G Bond-Smith7, J Yap8.   

Abstract

INTRODUCTION Healthcare associated infections (HCAIs) are falling following widespread and enforced introduction of guidelines, particularly those that have addressed antibiotic resistant pathogens such as methicillin resistant Staphylococcus aureus or emergent pathogens such as Clostridium difficile, but no such decline has been seen in the incidence of surgical site infection (SSI), either in the UK, the EU or the US. SSI is one of the HCAIs, which are all avoidable complications of a surgical patient's pathway through both nosocomial and community care. METHODS This report is based on a meeting held at The Royal College of Surgeons of England on 21 July 2016. Using PubMed, members of the panel reviewed the current use of antiseptics and antimicrobial sutures in their specialties to prevent SSI. FINDINGS The group agreed that wider use of antiseptics in surgical practice may help in reducing reliance on antibiotics in infection prevention and control, especially in the perioperative period of open elective colorectal, hepatobiliary and cardiac operative procedures. The wider use of antiseptics includes preoperative showering, promotion of hand hygiene, (including the appropriate use of surgical gloves), preoperative skin preparation (including management of hair removal), antimicrobial sutures and the management of dehisced surgical wounds after infection. The meeting placed emphasis on the level I evidence that supports the use of antimicrobial sutures, particularly in surgical procedures after which the SSI rate is high (colorectal and hepatobiliary surgery) or when a SSI can be life threatening even when the rate of SSI is low (cardiac surgery).

Entities:  

Keywords:  Antimicrobial suture; Care bundle; Meta-analysis; Surgical site infection; Systematic review; Triclosan

Mesh:

Substances:

Year:  2017        PMID: 28660816      PMCID: PMC5696981          DOI: 10.1308/rcsann.2017.0071

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  39 in total

1.  Healthcare savings associated with reduced infection rates using antimicrobial suture wound closure for cerebrospinal fluid shunt procedures.

Authors:  Jonathan Stone; Thomas J Gruber; Curtis J Rozzelle
Journal:  Pediatr Neurosurg       Date:  2010-05-05       Impact factor: 1.162

2.  The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection.

Authors:  S D ELEK; P E CONEN
Journal:  Br J Exp Pathol       Date:  1957-12

Review 3.  Clinical and microbiological aspects of biofilm-associated surgical site infections.

Authors:  Charles E Edmiston; Andrew J McBain; Christopher Roberts; David Leaper
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: A meta-analysis.

Authors:  Charles E Edmiston; Frederic C Daoud; David Leaper
Journal:  Surgery       Date:  2013-07       Impact factor: 3.982

Review 5.  Surgical site infection: poor compliance with guidelines and care bundles.

Authors:  David J Leaper; Judith Tanner; Martin Kiernan; Ojan Assadian; Charles E Edmiston
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

Review 6.  Meta-analysis of the potential economic impact following introduction of absorbable antimicrobial sutures.

Authors:  D J Leaper; C E Edmiston; C E Holy
Journal:  Br J Surg       Date:  2017-01-17       Impact factor: 6.939

7.  A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis.

Authors:  A P Wilson; T Treasure; M F Sturridge; R N Grüneberg
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Effectiveness of triclosan-coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomised controlled PROUD trial.

Authors:  Markus K Diener; Phillip Knebel; Meinhard Kieser; Philipp Schüler; Tobias S Schiergens; Vladimir Atanassov; Jens Neudecker; Erwin Stein; Henryk Thielemann; Reiner Kunz; Moritz von Frankenberg; Utz Schernikau; Jörg Bunse; Boris Jansen-Winkeln; Lars I Partecke; Gerald Prechtl; Julius Pochhammer; Ralf Bouchard; René Hodina; K Tobias E Beckurts; Lothar Leißner; Hans-Peter Lemmens; Friedrich Kallinowski; Oliver Thomusch; Daniel Seehofer; Thomas Simon; Alexander Hyhlik-Dürr; Christoph M Seiler; Thilo Hackert; Christoph Reissfelder; René Hennig; Colette Doerr-Harim; Christina Klose; Alexis Ulrich; Markus W Büchler
Journal:  Lancet       Date:  2014-04-07       Impact factor: 79.321

9.  Triclosan: applications and safety.

Authors:  H N Bhargava; P A Leonard
Journal:  Am J Infect Control       Date:  1996-06       Impact factor: 2.918

10.  Changes in the management of deep sternal wound infections: a 12-year review.

Authors:  Sarah Lonie; Jane Hallam; Michael Yii; Philip Davis; Andrew Newcomb; Ian Nixon; Alexander Rosalion; Sophie Ricketts
Journal:  ANZ J Surg       Date:  2015-09-01       Impact factor: 1.872

View more
  5 in total

1.  Comparison of Antimicrobial Activity Between Bacitracin-Soaked Sutures and Triclosan Coated Suture.

Authors:  Jeremy M Adkins; Roy Al Ahmar; Hongwei D Yu; Shane T Musick; Anthony M Alberico
Journal:  J Surg Res       Date:  2021-10-23       Impact factor: 2.192

Review 2.  Management of Perineal Wounds Following Pelvic Surgery.

Authors:  George A Mori; Jim P Tiernan
Journal:  Clin Colon Rectal Surg       Date:  2022-03-07

Review 3.  Engineering biomaterials to prevent post-operative infection and fibrosis.

Authors:  Aditya Josyula; Kunal S Parikh; Ian Pitha; Laura M Ensign
Journal:  Drug Deliv Transl Res       Date:  2021-03-12       Impact factor: 5.671

Review 4.  The antimicrobial peptides secreted by the chromaffin cells of the adrenal medulla link the neuroendocrine and immune systems: From basic to clinical studies.

Authors:  Francesco Scavello; Naji Kharouf; Philippe Lavalle; Youssef Haikel; Francis Schneider; Marie-Hélène Metz-Boutigue
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

5.  Anti-Biofilm Activity of the Fungal Phytotoxin Sphaeropsidin A Against Clinical Isolates of Antibiotic-Resistant Bacteria.

Authors:  Emanuela Roscetto; Marco Masi; Matilde Esposito; Roberta Di Lecce; Antonella Delicato; Lucia Maddau; Viola Calabrò; Antonio Evidente; Maria Rosaria Catania
Journal:  Toxins (Basel)       Date:  2020-07-08       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.